Drug intelligence / Profile preview

Tiangui Congying Granules

Development stage: Unknown
Lead developer: Beijing Increasepharm
Administration: Oral

Overview

Tiangui Congying Granules is a Traditional Chinese Medicine (TCM) botanical drug candidate developed by Yingkerui (Tianjin) Innovative Pharmaceutical Research for the treatment of menopausal syndrome. The formulation is specifically designed to address the "kidney deficiency and liver depression" pattern (shen xu gan yu) commonly diagnosed in TCM for perimenopausal and menopausal women. As a multi-herb granule formulation, it aims to alleviate symptoms such as hot flashes, mood swings, and sleep disturbances by restoring balance to the body's internal systems. It is currently undergoing Phase 2 clinical evaluation in China to establish its efficacy and safety profile.

Other names: 天癸充盈颗粒

Beyond the preview

Go deeper on Tiangui Congying Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiangui Congying Granules.

Explore the full profile